Coagulation factor VIII Inhibitor:ACnc:Pt:PPP:Qn:Chromo

Preferred Label : Coagulation factor VIII Inhibitor:ACnc:Pt:PPP:Qn:Chromo;

LOINC status : ACTIVE;

LOINC display name : Coagulation factor VIII inhibitor Chromogenic method Qn (PPP);

LOINC long common name : Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method;

LOINC short name : Fact VIII Inhib PPP Chro-aCnc;

LOINC description : This term is created for but not restricted in use to a Nijmegen modification of the classic Bethesda inhibitor titration assay using a chromogenic method. The use of a chromogenic method allows factor VIII inhibitor to be detected in patients receiving emicizumab / Hemlibra , a therapeutic that interferes with standard clot-based methods [PMID:29446525].;

Details

Origin ID

93450-5;

UMLS CUI

C5211969;

Has component
- Coagulation [LOINC component]
- Coagulation factor VIII [LOINC component]
- Coagulation factor VIII inhibitor [LOINC component]
- Factor VIII [LOINC component]
- VIII [LOINC component]
Has method
- Chromogenic (Enzyme) [LOINC method]
Has property
- Arbitrary Concentration [LOINC Property]
Has system
- Platelet poor plasma [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Part of panel
- Coagulation factor VIII activity & inhibitor panel:-:Pt:PPP:-:Chromo [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients